StockData
BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

biote Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$1.08−0.00 (-0.46%)

Close on Oct 19, 2026

Market cap
$30.92M
P/E (TTM)
10.8
Dividend yield
–

biote statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison

Valuation

MeasurebioteIndustry median
Market Cap$38.80M$197.05M
Enterprise Value$156.73M$106.56M
PE Ratio10.8020.52
PS Ratio0.213.93
P/FCF Ratio1.9518.25
P/OCF Ratio1.5913.78

Enterprise value

MeasurebioteIndustry median
EV / Sales0.852.69
EV / EBITDA8.4314.86
EV / EBIT10.6219.00
EV / FCF7.8921.02

Income (trailing twelve months)

MeasurebioteIndustry median
Revenue$183.53M$57.94M
Gross Profit$125.86M$90.47M
Operating Income$14.75M-$21.44M
Pretax Income$10.26M-$14.45M
Net Income$5.86M-$22.46M
EBITDA$18.60M-$16.91M
EPS (Diluted)$0.10-$0.83

Margins

MeasurebioteIndustry median
Gross Margin68.6%52.3%
Operating Margin8.04%-44.5%
Pretax Margin5.59%-13.0%
Profit Margin3.19%-39.2%
EBITDA Margin10.1%-31.3%
FCF Margin10.8%-8.85%

Returns

MeasurebioteIndustry median
Return on Assets (ROA)5.67%-41.0%
Return on Invested Capital (ROIC)45.7%-32.0%
Return on Capital Employed (ROCE)20.6%-37.8%

Growth

MeasurebioteIndustry median
Revenue Growth (YoY)-7.81%6.01%
Net Income Growth (YoY)-81.3%-37.7%
EPS Growth (YoY)-88.9%-29.2%
FCF Growth (YoY)-42.9%2.34%
Revenue Growth (3Y CAGR)5.23%2.25%

Balance sheet

MeasurebioteIndustry median
Cash & Short-Term Investments$11.17M$62.42M
Total Debt$121.50M$120.13M
Net Cash (Debt)-$110.33M$15.68M
Net Cash Per Share-$3.07$0.65
Equity (Book Value)-$65.79M$48.79M
Book Value Per Share-$1.83$1.36
Tangible Book Value-$75.27M$23.06M
Working Capital$12.94M$75.77M

Financial position

MeasurebioteIndustry median
Current Ratio1.433.30
Quick Ratio0.632.39
Debt / EBITDA6.533.35
Debt / FCF6.115.05
Net Debt / EBITDA5.932.22

Cash flow (trailing twelve months)

MeasurebioteIndustry median
Operating Cash Flow$24.37M-$12.35M
Capital Expenditures-$4.50M-$1.06M
Free Cash Flow$19.87M-$20.28M
FCF Per Share$0.55-$0.41

Efficiency

MeasurebioteIndustry median
Asset Turnover1.780.38
Inventory Turnover3.792.67
Revenue Per Employee$823.01K$398.96K
Profits Per Employee$26.26K-$732.08K
Employee Count22373

Dividends and yields

MeasurebioteIndustry median
Earnings Yield15.1%-21.2%
FCF Yield51.2%-7.64%
Payout Ratio19.9%47.7%
FCF Payout Ratio5.87%51.6%

Shares

MeasurebioteIndustry median
Shares Outstanding35,927,50059,128,900
Shares Change (YoY)-0.69%11.1%
Float27,568,60048,744,500
Shares Held by Insiders23.3%11.8%
Shares Held by Institutions36.6%59.4%

Taxes

MeasurebioteIndustry median
Income Tax$3.18M$91.50K
Effective Tax Rate31.0%20.6%

Scores

MeasurebioteIndustry median
Altman Z-Score1.880.10
Piotroski F-Score64
Beneish M-Score-2.70-2.62

Calculated by StockData from biote's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.